Prosecution Insights
Last updated: April 19, 2026

Natera, Inc.

25 pending office actions • 1 client

Portfolio Summary

25
Total Pending OAs
11
Final Rejections
14
Non-Final OAs

Client Portfolio (1 client)

Client (Assignee)Pending OAs
Natera, Inc. 25

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19399492 Untitled Natera, Inc. MUMMERT, STEPHANIE KANE 1681 Non-Final OA
19410320 Untitled Natera, Inc. MUMMERT, STEPHANIE KANE 1681 Non-Final OA
19028506 DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS Natera, Inc. FLINDERS, JEREMY C 1684 Final Rejection Jan 17, 2025
18885063 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Natera, Inc. MUMMERT, STEPHANIE KANE 1681 Final Rejection Sep 13, 2024
18812696 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Natera, Inc. MUMMERT, STEPHANIE KANE 1681 Non-Final OA Aug 22, 2024
18747138 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Natera, Inc. MUMMERT, STEPHANIE KANE 1681 Non-Final OA Jun 18, 2024
18747178 DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS Natera, Inc. BAILEY, STEVEN WILLIAM 1687 Final Rejection Jun 18, 2024
18733659 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Natera, Inc. MUMMERT, STEPHANIE KANE 1681 Final Rejection Jun 04, 2024
18376355 CELL LYSIS ASSAY FOR CELL-FREE DNA ANALYSIS Natera, Inc. PRIEST, AARON A 1681 Final Rejection Oct 03, 2023
18282390 METHODS FOR DETERMINATION OF TRANSPLANT REJECTION Natera, Inc. CHESTNUT, BARRY A 1672 Non-Final OA Sep 15, 2023
18227224 METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING Natera, Inc. PRIEST, AARON A 1681 Non-Final OA Jul 27, 2023
18227219 METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING Natera, Inc. PRIEST, AARON A 1681 Non-Final OA Jul 27, 2023
18220183 METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING Natera, Inc. BERTAGNA, ANGELA MARIE 1681 Non-Final OA Jul 10, 2023
17925693 METHODS FOR DETECTION OF DONOR-DERIVED CELL-FREE DNA Natera, Inc. GIAMMONA, FRANCESCA FILIPPA 1681 Final Rejection Nov 16, 2022
17868141 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Natera, Inc. MUMMERT, STEPHANIE KANE 1681 Non-Final OA Jul 19, 2022
17725341 METHODS FOR DETERMINING VELOCITY OF TUMOR GROWTH Natera, Inc. HANEY, AMANDA MARIE 1682 Non-Final OA Apr 20, 2022
17568854 DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS Natera, Inc. HORTH, LISA ANNE 1681 Non-Final OA Jan 05, 2022
17529536 METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING Natera, Inc. PRIEST, AARON A 1681 Final Rejection Nov 18, 2021
17600789 IMPROVED LIQUID BIOPSY USING SIZE SELECTION Natera, Inc. GIAMMONA, FRANCESCA FILIPPA 1681 Non-Final OA Oct 01, 2021
17465424 Systems and Methods for Detection of Aneuploidy Natera, Inc. NEGIN, RUSSELL SCOTT 1686 Non-Final OA Sep 02, 2021
17365786 SYSTEMS AND METHODS FOR DETERMINING ANEUPLOIDY RISK USING SAMPLE FETAL FRACTION Natera, Inc. KALLAL, ROBERT JAMES 1685 Final Rejection Jul 01, 2021
17252205 METHODS AND SYSTEMS FOR CALLING PLOIDY STATES USING A NEURAL NETWORK Natera, Inc. HAYES, JONATHAN EDWARD 1685 Non-Final OA Dec 14, 2020
16803782 METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING Natera, Inc. PRIEST, AARON A 1681 Final Rejection Feb 27, 2020
16734814 METHODS FOR SIMULTANEOUS AMPLIFICATION OF TARGET LOCI Natera, Inc. MUMMERT, STEPHANIE KANE 1681 Final Rejection Jan 06, 2020
16309271 COMPOSITIONS AND METHODS FOR DETECTION OF NUCLEIC ACID MUTATIONS Natera, Inc. SALMON, KATHERINE D 1682 Final Rejection Dec 12, 2018

Managing Natera, Inc.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month